Karen Benwell

Functional characterization of agonists at recombinant human 5‐HT_2A, 5‐HT_2B and 5‐HT_2C receptors in CHO‐K1 cells

Richard H. Porter, Karen Benwell, Helen Lamb et al. · British Journal of Pharmacology · 1999 · 354 citations · Full text

Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors

Anil Kumar Misra, Kathleen Quirk, Karen Benwell et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 237 citations · Full text

Signal Transduction, Biochemistry, Functional Selectivity +9

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake

Zoë D. Thornton-Jones, G.A. Kennett, Karen Benwell et al. · Pharmacology Biochemistry and Behavior · 2006 · 83 citations

Obesity, Metabolic Syndrome, Nutrition +12

Comparative effects of continuous infusion of <i>m</i>CPP, Ro 60‐0175 and <i>d</i>‐fenfluramine on food intake, water intake, body weight and locomotor activity in rats

S P Vickers, Karen Benwell, Richard H. Porter et al. · British Journal of Pharmacology · 2000 · 78 citations · Full text

Discovery of nonxanthine adenosine A_2Areceptor antagonists for the treatment of Parkinson’s disease

Scott Μ. Weiss, Karen Benwell, Ian A. Cliffe et al. · Neurology · 2003 · 77 citations